Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Clinical trial NCT05071209 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05071209
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Alveolar Rhabdomyosarcoma Recurrent Ewing Sarcoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Refractory Alveolar Rhabdomyosarcoma Refractory Ewing Sarcoma Refractory Lymphoma Refractory Malignant Solid Neoplasm

Start date: 2021-12-22
Primary completion: 2024-09-30
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.